Dr. Falk Loose

Dr. Falk Loose


Email falk.loose@​hoganlovells.com

Phone +49 89 290 12 295

Fax +49 89 290 12 222

LanguagesEnglish, French, German

Practice groupCorporate & Finance

Falk Loose advises on all tax aspects arising in the M&A, private equity and venture capital world and has extensive experience in distressed debt and insolvency scenarios.

Falk has helped clients manoeuvre through the "jungle" of German and international tax law for more than a decade. Besides his transactional lawyer role, he is his clients trusted counsel in difficult tax compliance, audit or even criminal tax law situations. Due to the complex German tax law, there is often room for deviating arguments, but also a good chance to make mistakes.

Falk advises many German and international clients of varying industry sectors, but especially many life science companies. He is a member of Hogan Lovells' global Life Science Transaction Team. His colleagues and clients appreciate his talent to explain complex tax law in a digestible manner. 

Falk is qualified both as a lawyer and certified tax advisor (Steuerberater). Before joining the firm, he was Principal Associate in another leading law firm's tax practice group. He studied law at the Free University of Berlin and the Université Pierre Mendès France in Grenoble, France. He obtained his doctorate of law from the Free University of Berlin with a doctoral thesis on European tax law.

Awards and recognitions


German Tax Firm of the Year
International Tax Review


JUVE Tax Law Firm of the Year 2009


JUVE shortlisted for the year

Education and admissions


Dr. iur., Freie Universität Berlin

Freie Universität Berlin

Université Pierre Mendès France Grenoble II



Related industries

Life Sciences and Health Care

Related practices


Representative experience

Advising Danfoss A/S on its worldwide sale of the gear motor business of Danfoss Bauer to Altra Holdings, Inc. and its joint-venture with Bosch Thermo Technik.

Advising Delticom AG on its acquisition of the Tirendo-Group.

Advising Merck&Co., Inc. on its worldwide license agreement with AiCuris GmbH & Co. KG regarding its HCMV portfolio.

Advising Genzyme Corp. on the sale of its diagnosis business to Sekisui Chemical Co., Ltd.

Advising One Rock Capital Partners in its portfolio acquisition of the gypsum, pharmaceutical and cosmetics business from Israel Chemicals.

Advising Perkin Elmer Inc. on the acquisition of the chemagen Biopolymer-Technologie AG.

Loading data